NCT00078637
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- San Antonio, Texas, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
2,141 public trials
305 recruiting studies
Lymphoma trial results
NCT01026415
- Conditions
- Carcinoma, Carcinomas, Disease, Hodgkin, +14 more
- Locations
-
- City of Hope Duarte, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States
- Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
NCT00655837
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- University of Colorado Aurora, Colorado, United States
- Oncology Specialists Park Ridge, Illinois, United States
Completed
Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies
NCT00430846
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Washington University St Louis, Missouri, United States
- Weill Cornell Medical College New York, United States
- University of Texas/MD Anderson Cancer Center Houston, Texas, United States
Completed
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
NCT01060904
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina Chapel Hill, North Carolina, United States
- MD Anderson Cancer Center / University of Texas Houston, Texas, United States
- British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada
Completed
Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma
NCT00079755
- Conditions
- Anaplastic Large-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Alabama, Birmingham Birmingham, Alabama, United States
- University of Califorinia at Los Angeles Los Angeles, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
- University of Miami Miami, Florida, United States
NCT00103779
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Stanford University Stanford, California, United States
- University of Miami Miami, Florida, United States
- Cornell University New York, United States
NCT01026233
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- University of Miami Hospital and Clinics, Miller School of Medicine Miami, Florida, United States
Completed
Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma
NCT00307177
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00666484
- Conditions
- Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
- Locations
-
- Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
- University College Hospital - London London, England, United Kingdom
- King's College Hospital London, England, United Kingdom
- Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle upon Tyne, England, United Kingdom